BioSpace News Archive

Policy

Extradited Scientist Found Guilty of Stealing GSK Secrets

Gongda Xue has been found guilty in a Philadephia courtroom of stealing trade secrets from GlaxoSmithKline. This comes after his sister, Yu Xue, was also convicted for a similar crime.

May 3, 2022
·
3 min read
·
Alex Keown
Drug Development

Horizon Rheumatoid Arthritis Trial Advances Following Successful Phase II Study

Horizon Therapeutics announced its Phase II dazodalibep (HZN-4920) clinical trial has met its primary endpoint. Dazodalibep is a treatment for patients with Rheumatoid Arthritis (RA).

May 3, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Business

At ISCT This Week, Cell & Gene Therapy Grows Up

BioSpace sat down with Sven Kili, 2022 ISCT Annual Meeting co-chair, to preview the event, which will focus on 4 key subject areas including launch and commercialization of cell and gene therapies.

May 3, 2022
·
5 min read
·
Heather McKenzie
Business

Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins

Denali Therapeutics, Inc. has announced that dosing has begun for participants of a Phase II clinical trial that intends to evaluate the potential of SAR443820 (DNL788) in patients with amyotrophic lateral sclerosis (ALS).

May 3, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development

Fast Track Designation in Hand, Graphite Bio Guns for Definitive Sickle Cell Cure

GPH101 is an investigational next-generation gene-edited autologous hematopoietic stem cell (HSC) therapy.

May 3, 2022
·
2 min read
·
Hannah Chudleigh
Policy

FDA Officials call COVID-19 the ‘New Normal’ in Op-Ed

Three long-time FDA officials, Dr. Peter Marks, Dr. Janet Woodcock and Dr. Robert Califf wrote an op-ed in JAMA describing the reality that COVID-19 represents “the new normal.”

May 3, 2022
·
3 min read
·
Mark Terry
Business

Fulgent Genetics Reports First Quarter 2022 Financial Results

Fulgent Genetics, Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, announced financial results for its first quarter ended March 31, 2022.

May 3, 2022
·
14 min read
Business

DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook

DermTech, Inc., a leader in precision dermatology enabled by a non-invasive skin genomics platform, reported its first-quarter 2022 financial results and affirmed its full-year 2022 outlook.

May 3, 2022
·
8 min read
Business

PerkinElmer Announces Financial Results for the First Quarter of 2022

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the first quarter ended April 3, 2022.

May 3, 2022
·
29 min read
Business

Masimo Reports First Quarter 2022 Financial Results

Masimo announced its financial results for the first quarter of 2022, ended April 2, 2022.

May 3, 2022
·
20 min read